The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma

Author： Kimpel Janine   Urbiola Carles   Koske Iris   Tober Reinhard   Banki Zoltan   Wollmann Guido   von Laer Dorothee  

Publisher： MDPI

E-ISSN： 1999-4915|10|3|108-108

ISSN： 1999-4915

Source： Viruses, Vol.10, Iss.3, 2018-03, pp. : 108-108

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumor Restrictions to Oncolytic Virus

By Vähä-Koskela Markus   Hinkkanen Ari  

Biomedicines, Vol. 2, Iss. 2, 2014-04 ,pp. : 163-194

MDPI

Access to resources Recommend Favorite

Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy

By Bishnoi Suman   Tiwari Ritudhwaj   Gupta Sharad   Byrareddy Siddappa N.   Nayak Debasis  

Viruses, Vol. 10, Iss. 2, 2018-02 ,pp. : 90-90

MDPI

Access to resources Recommend Favorite

Antiproliferative Activity of Double Point Modified Analogs of 1,25-Dihydroxyvitamin D2 Against Human Malignant Melanoma Cell Lines

By Piotrowska Anna   Wierzbicka Justyna   Nadkarni Sharmin   Brown Geoffrey   Kutner Andrzej   Żmijewski Michał A.  

International Journal of Molecular Sciences, Vol. 17, Iss. 1, 2016-01 ,pp. : 76-76

MDPI

Access to resources Recommend Favorite

Measles to the Rescue: A Review of Oncolytic Measles Virus

By Aref Sarah   Bailey Katharine   Fielding Adele  

Viruses, Vol. 8, Iss. 10, 2016-10 ,pp. : 294-294

MDPI

Access to resources Recommend Favorite

Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy

By Swift Stephanie L.   Stojdl David F.  

Viruses, Vol. 8, Iss. 2, 2016-02 ,pp. : 45-45

MDPI

Access to resources Recommend Favorite